Biotech entity
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention Health Sciences North, the most common co-covered peer. We currently track 1 Biotech story that mention Esmé St. Jean, all published on March 21, 2026.
Last mentioned: Mar 21, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention Health Sciences North, the most common co-covered peer. We currently track 1 Biotech story that mention Esmé St. Jean, all published on March 21, 2026. Each carries 3 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 12 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Esmé St. Jean. Shared-story counts are live from our verified record — not editorial picks.
A critical lack of local diagnostic infrastructure in Sudbury is forcing families of children with rare metabolic disorders into high-stakes waiting periods for essential lab results. The centralization of specialized testing to Southern Ontario hubs has created a dangerous 24-to-48-hour delay that compromises urgent clinical interventions.
Source: timminspress.com · saultstar.com
Esmé St. Jean is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
